THRD Third Harmonic Bio Inc
Price (delayed)
$3.55
Market cap
$160.12M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.09
Enterprise value
-$122.19M
Highlights
Third Harmonic Bio's debt has decreased by 19% YoY and by 6% QoQ
The equity rose by 6% YoY but it fell by 3.3% QoQ
The company's net income fell by 48% YoY and by 16% QoQ
The company's EPS fell by 40% YoY and by 14% QoQ
Key stats
What are the main financial stats of THRD
Market
Valuations
Earnings
Shares outstanding
45.1M
Market cap
$160.12M
Enterprise value
-$122.19M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.56
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$58.87M
Net income
-$45.47M
EBIT
-$45.47M
EBITDA
-$44.7M
Free cash flow
-$34.51M
Per share
Balance sheet
Liquidity
EPS
-$1.09
EPS diluted
-$1.09
Free cash flow per share
-$0.83
Book value per share
$6.33
Revenue per share
$0
TBVPS
$7.06
Total assets
$294.61M
Total liabilities
$9.46M
Debt
$3.21M
Equity
$285.15M
Working capital
$283.43M
Debt to equity
0.01
Current ratio
40.87
Quick ratio
40.16
Net debt/EBITDA
6.32
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-16%
Return on equity
-16.5%
Return on invested capital
-764.6%
Return on capital employed
-15.8%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
THRD stock price
How has the Third Harmonic Bio stock price performed over time
Intraday
5.65%
1 week
0.57%
1 month
2.9%
1 year
-59.38%
YTD
-65.5%
QTD
2.31%
Financial performance
How have Third Harmonic Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$58.87M
Net income
-$45.47M
Gross margin
N/A
Net margin
N/A
The company's net income fell by 48% YoY and by 16% QoQ
THRD's operating income is down by 34% year-on-year and by 11% since the previous quarter
Growth
What is Third Harmonic Bio's growth rate over time
Valuation
What is Third Harmonic Bio stock price valuation
P/E
N/A
P/B
0.56
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS fell by 40% YoY and by 14% QoQ
The stock's price to book (P/B) is 71% less than its last 4 quarters average of 1.8
The equity rose by 6% YoY but it fell by 3.3% QoQ
Efficiency
How efficient is Third Harmonic Bio business performance
THRD's ROIC has plunged by 76% YoY and by 23% from the previous quarter
THRD's return on assets is down by 48% year-on-year and by 14% since the previous quarter
The return on equity has declined by 47% year-on-year and by 14% since the previous quarter
Dividends
What is THRD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for THRD.
Financial health
How did Third Harmonic Bio financials performed over time
THRD's current ratio is down by 19% year-on-year and by 3.8% since the previous quarter
THRD's quick ratio is down by 19% year-on-year and by 4.3% since the previous quarter
Third Harmonic Bio's debt is 99% lower than its equity
Third Harmonic Bio's debt has decreased by 19% YoY and by 6% QoQ
The equity rose by 6% YoY but it fell by 3.3% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.